Yahoo

FDA recall: 230,000 bottles of anti-depressant Cymbalta over cancer risk. What to know

A nationwide recall of more than 233,000 bottles of duloxetine, an anti-depressant, has been announced by the Food and Drug Administration for possibly containing a chemical increasing the risk of ...
thedomains.com

Cost cymbalta

Do you need help with the cost of Cymbalta? Cymbalta was developed by Eli Lilly and Company for use in the treatment of depression, generalized anxiety disorder, major depressive disorder, ...
Medscape

The Efficacy of Duloxetine, Non-steroidal Anti-inflammatory Drugs, and Opioids in Osteoarthritis

Background: This meta-analysis assessed the efficacy of duloxetine versus other oral treatments used after failure of acetaminophen for management of patients with osteoarthritis. Methods: A ...
ascopubs.org

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Adherence to aromatase inhibitor (AI) therapy for early-stage breast cancer is limited by AI-associated musculoskeletal symptoms (AIMSS). Duloxetine is US Food and Drug Administration approved for ...
Reuters

Eli Lilly says FDA OKs wider Cymbalta use

NEW YORK, Feb 26 (Reuters) - Eli Lilly and Co. said on Monday that the U.S. Food and Drug Administration has added treatment of generalized anxiety disorder to the approved uses for the drugmaker's ...
The Indianapolis Star

FDA Duloxetine recall flags 7,100+ bottles of generic Cymbalta antidepressants

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...